Objectives To present current evidence on the etiology, risk factors, diagnosis, and
management of early and late neonatal sepsis. Source of data Non-systematic review of the …

Neonatal sepsis remains one of the key challenges of neonatal medicine, and together with
preterm birth, causes almost 50% of all deaths globally for children younger than 5 years …

Background There is limited data on antibiotic treatment in hospitalized neonates in low-and
middle-income countries (LMICs). We aimed to describe patterns of antibiotic use …

The most common early signs of sepsis in infants are fever or hypothermia, tachypnoea,
lethargy, or new parental reports of poor feeding. Consider sepsis in infants with an …

Innovative solutions are needed for the treatment of bacterial infections, and a range of
antibacterial molecules have been explored as alternatives to antibiotics. A different …

Background Neonatal sepsis contributes substantially to neonatal morbidity and mortality
and is an ongoing major global public health challenge particularly in develo** countries …

Background Sepsis is the third most common cause of death among neonates, with about
225,000 newborns dying every year globally. Data concerning the microbial etiology of …

Introduction Newborn sepsis accounts for more than a third of neonatal deaths globally and
one in five neonatal deaths in Ethiopia. The first-line treatment recommended by WHO is the …

Background Prediction modelling can greatly assist the health-care professionals in the
management of diseases, thus sparking interest in neonatal sepsis diagnosis. The main …

Background Neonatal sepsis is a leading cause of neonatal morbidity and mortality,
particularly in develo** countries. Time to recovery is an indicator of the severity of sepsis …